SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

25 Oct 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 1657.00 millions as compared to Rs. 1863.00 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 105.00 millions grew from Rs.-4.00 millionsOperating profit surged to 377.00 millions from the corresponding previous quarter of 192.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1657.00 1863.00 -11.06 3324.00 4037.00 -17.66 7847.00 8101.00 -3.14
Other Income 438.00 184.00 138.04 633.00 343.00 84.55 1034.00 1379.00 -25.02
PBIDT 377.00 192.00 96.35 584.00 393.00 48.60 1199.00 1410.00 -14.96
Interest 78.00 71.00 9.86 154.00 135.00 14.07 299.00 185.00 61.62
PBDT 299.00 121.00 147.11 318.00 258.00 23.26 900.00 1225.00 -26.53
Depreciation 133.00 119.00 11.76 264.00 233.00 13.30 483.00 432.00 11.81
PBT 166.00 2.00 8200.00 54.00 25.00 116.00 417.00 793.00 -47.41
TAX 61.00 6.00 916.67 51.00 10.00 410.00 101.00 294.00 -65.65
Deferred Tax 8.00 6.00 33.33 -2.00 6.00 -133.33 33.00 156.00 -78.85
PAT 105.00 -4.00 -2725.00 3.00 15.00 -80.00 316.00 499.00 -36.67
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 22.75 10.31 120.76 17.57 9.73 80.47 15.28 17.41 -12.21

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×